SNMMI Virtual Tumor Board – Challenging Cases of Lu 177 Therapy
Monday, July 27, 2026 | 12:00 pm ET
Sponsored by the SNMMI Theranostics Leadership and Operations Group (TLOG)

Organizer(s)/Moderator(s):
Aamna Hassan, MD

Speaker(s):
Aamna Hassan, MD
Sadaf Mufty, MD
Hajra Ilyas, MD
Sana Munir Gill, MD
Shaukat Khanum Memorial Cancer Hospital and Research Center

Course Objectives
Upon completion of this session, participants will be able to:

1. Discuss selection criteria of patients for Lu177 therapy
2. Identify possible side effects of Lu177 therapy
3. Discuss pros and cons of re-challenge therapy  

CE Information:
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.